Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA PFIZER AUROBINDO PHARMA/
PFIZER
 
P/E (TTM) x 23.0 38.2 60.1% View Chart
P/BV x 2.4 6.0 39.8% View Chart
Dividend Yield % 0.3 1.7 16.5%  

Financials

 AUROBINDO PHARMA   PFIZER
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
PFIZER
Mar-23
AUROBINDO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs7154,662 15.3%   
Low Rs3973,407 11.7%   
Sales per share (Unadj.) Rs424.2530.0 80.0%  
Earnings per share (Unadj.) Rs32.9136.4 24.1%  
Cash flow per share (Unadj.) Rs54.1159.4 34.0%  
Dividends per share (Unadj.) Rs3.0070.00 4.3%  
Avg Dividend yield %0.51.7 31.1%  
Book value per share (Unadj.) Rs458.1701.0 65.3%  
Shares outstanding (eoy) m585.9445.75 1,280.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.37.6 17.2%   
Avg P/E ratio x16.929.6 57.1%  
P/CF ratio (eoy) x10.325.3 40.6%  
Price / Book Value ratio x1.25.8 21.1%  
Dividend payout %9.151.3 17.8%   
Avg Mkt Cap Rs m325,753184,576 176.5%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2233,317 1,061.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,55424,248 1,025.1%  
Other income Rs m2,9061,011 287.6%   
Total revenues Rs m251,46025,258 995.6%   
Gross profit Rs m37,0708,420 440.3%  
Depreciation Rs m12,4461,055 1,179.6%   
Interest Rs m1,405135 1,042.1%   
Profit before tax Rs m26,1258,240 317.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8492,001 342.3%   
Profit after tax Rs m19,2776,239 309.0%  
Gross profit margin %14.934.7 43.0%  
Effective tax rate %26.224.3 108.0%   
Net profit margin %7.825.7 30.1%  
BALANCE SHEET DATA
Current assets Rs m214,59924,933 860.7%   
Current liabilities Rs m114,9386,574 1,748.5%   
Net working cap to sales %40.175.7 53.0%  
Current ratio x1.93.8 49.2%  
Inventory Days Days2193 22.1%  
Debtors Days Days662 2,871.7%  
Net fixed assets Rs m176,66813,780 1,282.1%   
Share capital Rs m586458 128.1%   
"Free" reserves Rs m267,81331,616 847.1%   
Net worth Rs m268,39932,073 836.8%   
Long term debt Rs m6,1900-   
Total assets Rs m392,12539,031 1,004.7%  
Interest coverage x19.662.1 31.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.6 102.0%   
Return on assets %5.316.3 32.3%  
Return on equity %7.219.5 36.9%  
Return on capital %10.026.1 38.4%  
Exports to sales %33.72.8 1,187.2%   
Imports to sales %15.30 44,201.4%   
Exports (fob) Rs m83,703688 12,169.7%   
Imports (cif) Rs m38,0608 453,092.9%   
Fx inflow Rs m85,483688 12,428.5%   
Fx outflow Rs m41,4478 493,420.2%   
Net fx Rs m44,036679 6,481.6%   
CASH FLOW
From Operations Rs m23,8683,557 671.0%  
From Investments Rs m-39,778-361 11,034.0%  
From Financial Activity Rs m18,144-3,458 -524.7%  
Net Cashflow Rs m2,298-262 -878.3%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 63.9 4.8%  
Indian inst/Mut Fund % 41.3 18.2 227.3%  
FIIs % 20.7 3.0 683.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 36.1 133.5%  
Shareholders   241,944 112,456 215.1%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Pfizer Share Price Performance

Period Aurobindo Pharma Pfizer S&P BSE HEALTHCARE
1-Day 1.82% -4.80% 1.18%
1-Month 5.96% -8.24% -0.75%
1-Year 113.07% 21.78% 61.82%
3-Year CAGR 7.78% -2.07% 18.16%
5-Year CAGR 7.18% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.